| Jennifer Sue Engle, MD | |
|
3290 West Big Beaver, Suite 410, Troy, MI 48084 | |
| (248) 816-6300 | |
| (248) 816-6335 |
| Full Name | Jennifer Sue Engle |
|---|---|
| Gender | Female |
| Speciality | Vascular Surgery |
| Experience | 34 Years |
| Location | 3290 West Big Beaver, Troy, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487761284 | NPI | - | NPPES |
| 0633076 | Other | MI | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | 4301056164 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaumont Hospital Royal Oak | Royal oak, MI | Hospital |
| Beaumont Hospital, Troy | Troy, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Somerset Venous Center Pc | 0648298851 | 2 |
News Archive
Boehringer Ingelheim announced the publication of new data from the Phase IIIb OTEMTO® 1&2 trials (NCT01964352/NCT02006732), which show Spiolto® Respimat® (tiotropium/olodaterol) provides consistent, clinically meaningful improvements in quality of life versus placebo in patients with COPD
A research team co-led by Dr. Stephen Scherer, Senior Scientist at The Hospital for Sick Children (SickKids) was awarded an $8.9 million grant today from the Global Leadership Round in Genomics & Life Sciences (GL(2)), which is part of the Ontario Research Fund (ORF) by the Ministry of Research and Innovation (MRI).
The extraordinary shareholders' meeting of convened to approve the acquisition of the US company, RedPath Integrated Pathology, will be held on first notice, on Monday, June 28, 2010 at 17:30 CET, at the Company's headquarters, 63-65 boulevard Masséna, 75013 Paris, France. If the quorum is not met, the meeting will be held, on second notice, on July 8, 2010, at 16:00 CET, at the Company's headquarters.
CoaguSense™, Inc., a diagnostic device company that has been in stealth mode for the past two years, today unveiled the first portable point-of-care Prothrombin Time/International Normalized Ratio (PT/INR) analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications such as Coumadin® or warfarin.
According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), postmenopausal HIV-infected women have a high prevalence of low bone mineral density and high bone turnover placing them at high risk for future bone fractures.
› Verified 1 days ago
| Entity Name | Somerset Venous Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740396043 PECOS PAC ID: 0648298851 Enrollment ID: O20051107000353 |
News Archive
Boehringer Ingelheim announced the publication of new data from the Phase IIIb OTEMTO® 1&2 trials (NCT01964352/NCT02006732), which show Spiolto® Respimat® (tiotropium/olodaterol) provides consistent, clinically meaningful improvements in quality of life versus placebo in patients with COPD
A research team co-led by Dr. Stephen Scherer, Senior Scientist at The Hospital for Sick Children (SickKids) was awarded an $8.9 million grant today from the Global Leadership Round in Genomics & Life Sciences (GL(2)), which is part of the Ontario Research Fund (ORF) by the Ministry of Research and Innovation (MRI).
The extraordinary shareholders' meeting of convened to approve the acquisition of the US company, RedPath Integrated Pathology, will be held on first notice, on Monday, June 28, 2010 at 17:30 CET, at the Company's headquarters, 63-65 boulevard Masséna, 75013 Paris, France. If the quorum is not met, the meeting will be held, on second notice, on July 8, 2010, at 16:00 CET, at the Company's headquarters.
CoaguSense™, Inc., a diagnostic device company that has been in stealth mode for the past two years, today unveiled the first portable point-of-care Prothrombin Time/International Normalized Ratio (PT/INR) analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications such as Coumadin® or warfarin.
According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), postmenopausal HIV-infected women have a high prevalence of low bone mineral density and high bone turnover placing them at high risk for future bone fractures.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Sue Engle, MD 3290 W Big Beaver, Suite 410, Troy, MI 48084 Ph: (248) 816-6300 | Jennifer Sue Engle, MD 3290 West Big Beaver, Suite 410, Troy, MI 48084 Ph: (248) 816-6300 |
News Archive
Boehringer Ingelheim announced the publication of new data from the Phase IIIb OTEMTO® 1&2 trials (NCT01964352/NCT02006732), which show Spiolto® Respimat® (tiotropium/olodaterol) provides consistent, clinically meaningful improvements in quality of life versus placebo in patients with COPD
A research team co-led by Dr. Stephen Scherer, Senior Scientist at The Hospital for Sick Children (SickKids) was awarded an $8.9 million grant today from the Global Leadership Round in Genomics & Life Sciences (GL(2)), which is part of the Ontario Research Fund (ORF) by the Ministry of Research and Innovation (MRI).
The extraordinary shareholders' meeting of convened to approve the acquisition of the US company, RedPath Integrated Pathology, will be held on first notice, on Monday, June 28, 2010 at 17:30 CET, at the Company's headquarters, 63-65 boulevard Masséna, 75013 Paris, France. If the quorum is not met, the meeting will be held, on second notice, on July 8, 2010, at 16:00 CET, at the Company's headquarters.
CoaguSense™, Inc., a diagnostic device company that has been in stealth mode for the past two years, today unveiled the first portable point-of-care Prothrombin Time/International Normalized Ratio (PT/INR) analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications such as Coumadin® or warfarin.
According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), postmenopausal HIV-infected women have a high prevalence of low bone mineral density and high bone turnover placing them at high risk for future bone fractures.
› Verified 1 days ago
Dr. Danielle Deluca-pytell, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 3290 W Big Beaver Rd Ste 412, Troy, MI 48084 Phone: 248-885-8858 | |
Dr. Mark S Friedland Md Pc, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 44199 Dequindre Rd, Ste 623, Troy, MI 48085 Phone: 248-828-5707 Fax: 248-828-5702 | |
Jonathan William Lezotte, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 44199 Dequindre Rd Ste 315, Troy, MI 48085 Phone: 248-964-1170 Fax: 248-964-1188 | |
Dr. Mark L Shapiro, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 44201 Dequindre Rd, Troy, MI 48085 Phone: 284-964-1187 | |
Dr. Corinne Dianne Costellic, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 44199 Dequindre Rd Ste 612, Troy, MI 48085 Phone: 248-964-5170 Fax: 248-964-5175 | |
Inad Naim Janineh, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 5600 Rochester Rd, Troy, MI 48085 Phone: 586-263-2300 Fax: 586-263-2614 | |
Mr. Pravin P Puri, MD Surgery Medicare: May Accept Medicare Assignments Practice Location: 1080 Kirts Blvd, Suite 700, Troy, MI 48084 Phone: 248-362-2300 Fax: 248-362-5272 |